For Jesy Nelson, the news that newborn screening for spinal muscular atrophy (SMA) is set to begin in England this October carries deeply personal meaning.

The former Little Mix singer became a pᴀssionate advocate for newborn SMA screening after her twin daughters, Ocean Jade and Story Monroe, were diagnosed with the rare genetic condition.

Now, after months of speaking publicly about their experience and campaigning alongside other families, Jesy is seeing an important step forward.

A PERSONAL FIGHT FOR EARLIER ANSWERS

SMA is a rare inherited condition that affects the motor neurons responsible for muscle movement. Depending on its type and severity, it can affect movement, breathing and swallowing.

One of the most important factors in treatment is early detection. The UK National Screening Committee says that identifying SMA before symptoms appear can allow babies to be referred quickly for ᴀssessment and treatment, potentially improving outcomes.

For Jesy, that possibility has made the campaign especially emotional.

After her daughters’ diagnosis, she began calling for SMA to be added to the newborn blood-spot, or “heel-prick,” screening programme.

Her campaign attracted significant public support, with a peтιтion gathering more than 100,000 signatures.

SCREENING IS DUE TO BEGIN THIS OCTOBER

The UK National Screening Committee has confirmed that an in-service evaluation of newborn SMA screening in England is scheduled to begin in October 2026.

The evaluation will initially operate through seven newborn screening laboratories that already have the necessary equipment. Researchers will ᴀssess how the screening works in real NHS settings, including its feasibility, effectiveness, acceptability and cost-effectiveness.

The findings will then help inform a future decision about whether SMA screening should become a permanent part of England’s newborn screening programme.

That means the October launch is an important step, but it is not yet the same as a permanent nationwide programme.

“A DAY OF HOPE”

Jesy has described the development as a major milestone for families affected by SMA.

She has spoken about how earlier detection could potentially give babies access to treatment before symptoms cause irreversible damage.

“Today is a day of hope,” she said after the announcement, describing the opportunity for future families to receive earlier diagnoses and better possible outcomes.

Her campaign has also highlighted the experiences of other parents who have faced the uncertainty of receiving an SMA diagnosis only after symptoms became noticeable.

A MOTHER’S HOPE FOR OTHER FAMILIES

Jesy’s own daughters remain at the heart of her advocacy.

Their diagnosis has been an intensely personal experience, but she has chosen to use her platform to raise awareness and encourage earlier testing for other babies.

The new screening evaluation cannot change what happened to her own children. But for Jesy and many other families affected by SMA, the hope is that it could help future babies receive answers and treatment much earlier.

As England prepares to begin the evaluation this October, her message is ultimately about looking forward — toward a future in which families may have the opportunity to know sooner and act sooner.

💙 For families living with SMA, that possibility represents more than a medical development. It represents hope.

Source: UK National Screening Committee — SMA newborn screening evaluation | BBC News — Jesy Nelson and newborn SMA screening | Sky News — Jesy Nelson celebrates SMA screening plans